TaeWoong Medical was founded in 1991 and obtained FDA and CE approval for Niti-S™ brand products with excellence through product quality and technical expertise.
As a leading medical device company, TaeWoong researches, designs and manufactures a full portfolio of ablation products, including thyroid, biliary, pancreatic, uterine fibroid, breast, liver, bone and renal. A secondary division is our worldwide leading non-vascular stents including esophageal, biliary and numerous other GI indications.
We will always continue to deliver our values and invest our passion and energy for the greater benefit of all patients.
Interventional Oncology (IO)